Skip to main content

Table 6 Median survival time by AFP level of 200 ng/ml at baseline and post initial TACE

From: Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

AFP groups

n

Median Survival time, months (IQR)

P value

AFP0 < 200 and AFP1 < 200

135

34.7 (19.9 - 56.1)

0.0001

AFP0 < 200 and AFP1 ≥ 200

5

19.4 (14.2 - 29.6)

AFP0 ≥ 200 and AFP1 < 200

12

19.9 (13.3 - 27.7)

AFP0 ≥ 200 and AFP1 ≥ 200

25

18.2 (9.2 - 26.1)